Search for: "In Re Purdue"
Results 41 - 60
of 278
Sorted by Relevance
|
Sort by Date
26 Apr 2007, 2:30 pm
"They're quite clearly the same," says Jeanne Loring of the Burnham Institute for Medical Research in La Jolla, California. [read post]
21 Aug 2012, 8:19 am
Neary (In re Pilgrim’s Pride Corp.) [read post]
10 Jan 2013, 7:40 am
Purdue Pharma, slip op. at 6. [read post]
28 Sep 2011, 8:22 pm
If they could get away with canceling elections, they would do it...ADDED: Sorry about the Purdue/Perdue misspelling. [read post]
21 Aug 2012, 8:31 am
Neary (In re Pilgrim’s Pride Corp.) [read post]
17 Oct 2019, 4:36 pm
Sometimes they're things I just pound out with (in retrospect) insufficient thought. [read post]
14 Aug 2012, 8:20 am
In In re Walter F. [read post]
6 Feb 2008, 9:18 am
I read Are You Living Your Life Like You're Planning to Fail on Ms. [read post]
13 Nov 2023, 9:05 pm
" (ii) The 1970s case is In re Equity Funding Corp. of America, 396 F. [read post]
7 Dec 2011, 11:32 am
Purdue Pharma Co., 435 F. [read post]
23 Jan 2015, 7:00 am
Ecubed offers a 100% online learning environment, with classes from schools like Purdue University and Creighton University. [read post]
17 Apr 2018, 8:00 am
Bodenhamer, Indiana University-Purdue University, Indianapolis. [read post]
16 Apr 2013, 8:36 pm
Purdue Pharma Prods. [read post]
1 Jan 2014, 5:07 pm
The firm is very excited to have Tim on board, and we're looking forward to his continued success here. [read post]
9 Jun 2014, 6:07 pm
The firm is very excited to have Tim on board, and we're looking forward to his continued success here. [read post]
21 Apr 2014, 7:53 pm
Purdue Pharma L.P., 737 F.3d 908 (4th Cir. 2013).As Mr. [read post]
2 Jul 2007, 2:51 pm
Par (07-255); Purdue et al. v. [read post]
10 Mar 2007, 4:01 pm
The other day, I received a seemingly unprompted e-mail from Purdue University professor A.G. [read post]
1 Oct 2020, 3:27 am
Her ruling in the Purdue Title IX case was exemplary. [read post]
16 Dec 2020, 8:17 am
Purdue was a McKinsey client, and the consultants now are re-examining their advice to the drug maker on how to fire up OxyContin sales and whether these suggestions fell short of the firm’s own standards. [read post]
